1. Kropp, H., Sundelof, J. G., Bohn, D. L., Kahan, F. M.: Improved urinary tract bioavailability of MK0787 (N-formimidoyl thienamycin) when coadministered with inhibitors of renal dehydropeptidase I. 20th Interscience Conference on Antimicrobial Agents and Chemotherapy, New Orleans, La. (1980) Abstr. No. 270.
2. Kropp, H., Sundelof, J. G., Hajdu, R., Kahan, F. M. Metabolism of thienamycin and related carbapenem antibiotics by the renal dipeptidase, dehydropeptidase I. Antimicrob. Agents Chemother. 22 (1982) 62–70.
3. Braveny, I., Machka, K., Elsser, R. Antibacterial activity of N-formimidoyl thienamycin in comparison with cefotaxime, lamoxactam, cefoperazone, piperacillin and gentamicin. Infection 10 (1982) 45–49.
4. Burkhardt, F., Tucher, R. Die Wirkung von Thienamycin auf multiresistente Erreger. Krankenhausarzt 56 (1982) 381–390.
5. Cohn, D. L., Reimer, R. G., Reller, L. B. Comparativein vitro activity of MK 0787 (N-formimidoyl thienamycin) against 540 blood culture isolates. J. Antimicrob. Chemother. 9 (1982) 183–194.